Pranjali Dalvi

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Radical Prostatectomy

Top Venues

Cardiovascular research

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Eduardo Nunes Chini, Guillermo Agorrody, Laura Colman, Sonu Kashyap, Julianna D Zeidler, Claudia Christiano Silva Chini, Gina M Warner, Katie L Thompson, Pranjali Dalvi, Felipe Cesar Beckedorff, Sanam Ebtehaj, Joerg Herrmann, Wim van Schooten, Eduardo Nunes Chini
Ecto-CD38-NADase inhibition modulates cardiac metabolism and protects mice against doxorubicin-induced cardiotoxicity. Cardiovascular research 120 (3) (2024)
Thais R Peclat, Guillermo Agorrody, Laura Colman, Sonu Kashyap, Julianna D Zeidler, Claudia Christiano Silva Chini, Gina M Warner, Katie L Thompson, Pranjali Dalvi, Felipe Cesar Beckedorff, Sanam Ebtehaj, Joerg Herrmann, Wim van Schooten, Eduardo Nunes Chini
Ecto-CD38-NADase inhibition modulates cardiac metabolism and protects mice against Doxorubicin-induced cardiotoxicity. Cardiovascular research (2024)
Eduardo Nunes Chini, Guillermo Agorrody, Laura Colman, Sonu Kashyap, Julianna D Zeidler, Claudia Christiano Silva Chini, Gina M Warner, Katie L Thompson, Pranjali Dalvi, Felipe Cesar Beckedorff, Sanam Ebtehaj, Joerg Herrmann, Wim van Schooten, Eduardo Nunes Chini
Ecto-CD38-NADase inhibition modulates cardiac metabolism and protects mice against doxorubicin-induced cardiotoxicity. Cardiovascular research 120 (3) (2024)
Eduardo Nunes Chini, Guillermo Agorrody, Laura Colman, Sonu Kashyap, Julianna D Zeidler, Claudia Christiano Silva Chini, Gina M Warner, Katie L Thompson, Pranjali Dalvi, Felipe Cesar Beckedorff, Sanam Ebtehaj, Joerg Herrmann, Wim van Schooten, Eduardo Nunes Chini
Ecto-CD38-NADase inhibition modulates cardiac metabolism and protects mice against doxorubicin-induced cardiotoxicity. Cardiovascular research 120 (3) (2024)
Brian C Avanzino, Kirthana Prabhakar, Pranjali Dalvi, Sharon Hartstein, Hannes Kehm, Aarti Balasubramani, Andrew A Boudreau, Ben Buelow, Karen Chang, Laura M Davison, Suhasini Iyer, Vidyut Kalwit, Kristin Lewis Wilson, Harbani K Malik-Chaudhry, Will Pierson, Geovanni Pineda, Udaya S Rangaswamy, Sowmya Saiganesh, Ute Schellenberger, Harshad S Ugamraj, Rodolfovan D Yabut, Roland Buelow, Jocelyn Chapman, Nathan D Trinklein, Katherine E Harris
A T-cell engaging bispecific antibody with a tumor-selective bivalent folate receptor alpha binding arm for the treatment of ovarian cancer. Oncoimmunology 11 (1) (2022)
Kevin Dang, Giulia Castello, Starlynn C Clarke, Yuping Li, Aarti Balasubramani, Andrew Boudreau, Laura Davison, Katherine E Harris, Duy Pham, Preethi Sankaran, Harshad S Ugamraj, Rong Deng, Serena Kwek, Alec Starzinski, Suhasini Iyer, Wim van Schooten, Ute Schellenberger, Wenchao Sun, Nathan D Trinklein, Roland Buelow, Ben Buelow, Lawrence Fong, Pranjali Dalvi
Attenuating CD3 affinity in a PSMAxCD3 bispecific antibody enables killing of prostate tumor cells with reduced cytokine release. Journal for immunotherapy of cancer 9 (6) (2021)